Invention Grant
- Patent Title: Indazole carboxamides as kinase inhibitors
-
Application No.: US17274227Application Date: 2019-09-12
-
Publication No.: US12084426B2Publication Date: 2024-09-10
- Inventor: Junqing Guo , Carolyn Diane Dzierba , Amy C. Hart , John E. Macor , William J. Pitts
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Mary K. VanAtten
- International Application: PCT/US2019/050721 2019.09.12
- International Announcement: WO2020/056074A 2020.03.19
- Date entered country: 2021-03-08
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07D401/14 ; C07D403/04 ; C07D413/04 ; C07D413/14
Abstract:
Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof, are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein.
Public/Granted literature
- US20210309633A1 INDAZOLE CARBOXAMIDES AS KINASE INHIBITORS Public/Granted day:2021-10-07
Information query
